Blog

Spinout from Lexington’s Agenus raises $40M in IPO

drjenniferbuell79900xx2637-1758-1-0

While MiNK Therapeutics Inc. is incorporated in New York City, half of employees and its main operations will be primarily based in Lexington, according to a company spokeswoman.

Read More